25 related articles for article (PubMed ID: 3939276)
1. Gabexate mesilate (Foy) as an anticoagulant in extracorporeal circulation in dogs and sheep.
Oedekoven B; Bey R; Mottaghy K; Schmid-Schönbein H
Thromb Haemost; 1984 Dec; 52(3):329-32. PubMed ID: 6442472
[TBL] [Abstract][Full Text] [Related]
2. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
Heitz J; Semsch B; Emde C; Jansen U; Schäfer JH
Z Gastroenterol; 1990 Apr; 28(4):192-7. PubMed ID: 2119091
[TBL] [Abstract][Full Text] [Related]
3. Reduction of unfavourable effects of heparin with use of gabexate mesilate in dialysis.
Matsui N; Nakagawa S; Sasaoka T; Suenaga M; Yoshiyama N; Takeuchi J
Proc Eur Dial Transplant Assoc; 1979; 16():135-40. PubMed ID: 121458
[TBL] [Abstract][Full Text] [Related]
4. [Beneficial characteristics of protease inhibitor as an anticoagulant for extracorporeal circulation].
Akizawa T
Rinsho Ketsueki; 1990 Jun; 31(6):782-6. PubMed ID: 2214168
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal anticoagulation using a serine protease inhibitor in hemodialysis in sheep.
Mottaghy K; Oedekoven B; Bey R; Schmid-Schönbein H
Trans Am Soc Artif Intern Organs; 1985; 31():534-6. PubMed ID: 3939276
[No Abstract] [Full Text] [Related]
6. [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
Kaizu K; Uriu K; Ikeda M
Nihon Rinsho; 2004 May; 62 Suppl 5():46-9. PubMed ID: 15197886
[No Abstract] [Full Text] [Related]
7. [Artificial organs and thrombosis: hemodialysis].
Matsui N
Nihon Rinsho; 1986 May; 44(5):1211-17. PubMed ID: 3091886
[No Abstract] [Full Text] [Related]
8. [Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation].
Tsukagoshi S
Gan To Kagaku Ryoho; 2000 May; 27(5):767-74. PubMed ID: 10832450
[TBL] [Abstract][Full Text] [Related]
9. [Use of prostaglandins in extracorporeal circulation and hemodialysis].
Zaorska B
Pol Tyg Lek; 1981 Jun; 36(23):857-60. PubMed ID: 7024949
[No Abstract] [Full Text] [Related]
10. [Biocompatibility and extracorporeal circulation].
Camici M
Clin Ter; 1995 Nov; 146(11):713-9. PubMed ID: 8720347
[TBL] [Abstract][Full Text] [Related]
11. [Premises to the study of blood coagulation changes in the course of extracorporeal circulation].
Respighi E; Marcazzan E; Panzeri E
Arch Chir Torac Cardiovasc; 1968; 25(3):207-27. PubMed ID: 4910329
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
